Chuang WL - Search Results

1

Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 2 or 3.

Nelson DR, Benhamou Y, Chuang WL, Lawitz EJ, Rodriguez-Torres M, Flisiak R, Rasenack JW, Kryczka W, Lee CM, Bain VG, Pianko S, Patel K, Cronin PW, Pulkstenis E, Subramanian GM, McHutchison JG; ACHIEVE-2/3 Study Team. Nelson DR, et al. Among authors: chuang wl. Gastroenterology. 2010 Oct;139(4):1267-76. doi: 10.1053/j.gastro.2010.06.062. Epub 2010 Jul 1. Gastroenterology. 2010. PMID: 20600017 Free PMC article. Clinical Trial.

2

Serotyping and genotyping of hepatitis C virus in Taiwanese patients with type C chronic liver disease and uraemic patients on maintenance haemodialysis.

Yu ML, Wang LY, Chuang WL, Dai CY, Sung MH, Chen SC, Lin ZY, Hsieh MY, Tsai JF, Chang WY. Yu ML, et al. Among authors: chuang wl. J Gastroenterol Hepatol. 2000 Jul;15(7):792-7. doi: 10.1046/j.1440-1746.2000.02195.x. J Gastroenterol Hepatol. 2000. PMID: 10937687

3

Status and natural course of GB virus C/hepatitis G virus infection among high-risk groups and volunteer blood donors in Taiwan.

Yu ML, Chuang WL, Wang LY, Dai CY, Chiou SS, Sung MH, Chang CS, Chen SC, Wang CS, Chang TT, Chang WY. Yu ML, et al. Among authors: chuang wl. J Gastroenterol Hepatol. 2000 Dec;15(12):1404-10. doi: 10.1046/j.1440-1746.2000.02359.x. J Gastroenterol Hepatol. 2000. PMID: 11197051

4

Incidence and associated factors of neutralizing anti-interferon antibodies among chronic hepatitis C patients treated with interferon in Taiwan.

Hou C, Chuang WL, Yu ML, Dai CY, Chen SC, Lin ZY, Hsieh MY, Wang LY, Tsai JF, Chang WY. Hou C, et al. Among authors: chuang wl. Scand J Gastroenterol. 2000 Dec;35(12):1288-93. doi: 10.1080/003655200453647. Scand J Gastroenterol. 2000. PMID: 11199369 Clinical Trial.

5

Influence of hepatitis C virus on the profiles of patients with chronic hepatitis B virus infection.

Dai CY, Yu ML, Chuang WL, Lin ZY, Chen SC, Hsieh MY, Wang LY, Tsai JF, Chang WY. Dai CY, et al. Among authors: chuang wl. J Gastroenterol Hepatol. 2001 Jun;16(6):636-40. doi: 10.1046/j.1440-1746.2001.02494.x. J Gastroenterol Hepatol. 2001. PMID: 11422616

6

Co-infection of SENV-D among chronic hepatitis C patients treated with combination therapy with high-dose interferon-alfa and ribavirin.

Dai CY, Chuang WL, Chang WY, Chen SC, Lee LP, Hsieh MY, Hou NJ, Lin ZY, Hsieh MY, Wang LY, Yu ML. Dai CY, et al. Among authors: chuang wl. World J Gastroenterol. 2005 Jul 21;11(27):4241-5. doi: 10.3748/wjg.v11.i27.4241. World J Gastroenterol. 2005. PMID: 16015698 Free PMC article. Clinical Trial.

7

Genetic predisposition of responsiveness to therapy for chronic hepatitis C.

Hwang Y, Chen EY, Gu ZJ, Chuang WL, Yu ML, Lai MY, Chao YC, Lee CM, Wang JH, Dai CY, Shian-Jy Bey M, Liao YT, Chen PJ, Chen DS. Hwang Y, et al. Among authors: chuang wl. Pharmacogenomics. 2006 Jul;7(5):697-709. doi: 10.2217/14622416.7.5.697. Pharmacogenomics. 2006. PMID: 16886895

8

A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy.

Yu ML, Lin SM, Lee CM, Dai CY, Chang WY, Chen SC, Lee LP, Lin ZY, Hsieh MY, Wang LY, Chuang WL, Liaw YF. Yu ML, et al. Among authors: chuang wl. Hepatology. 2006 Nov;44(5):1086-97. doi: 10.1002/hep.21363. Hepatology. 2006. PMID: 17058238 Clinical Trial.

9

A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan.

Yu ML, Lin SM, Chuang WL, Dai CY, Wang JH, Lu SN, Sheen IS, Chang WY, Lee CM, Liaw YF. Yu ML, et al. Among authors: chuang wl. Antivir Ther. 2006;11(8):985-94. Antivir Ther. 2006. PMID: 17302368

10

Outcome of chronic hepatitis C patients who required early termination of pegylated interferon-alpha plus ribavirin combination therapy.

Yu ML, Dai CY, Lee LP, Hsieh MY, Hou NJ, Huang JF, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Chuang WL. Yu ML, et al. Among authors: chuang wl. Antivir Ther. 2006;11(8):1015-9. Antivir Ther. 2006. PMID: 17302371 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

658 results

Search Page